Compass Minerals International (CMP) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
11 Jan, 2026Executive summary
Fiscal 2024 was a transitional year with leadership changes, a strategic refocus on Salt and Plant Nutrition, and the termination of the lithium project.
Net loss for fiscal 2024 was $206.1 million, driven by $191 million in non-cash impairments and restructuring charges.
Adjusted EBITDA for fiscal 2024 rose 4% year-over-year to $206.3 million despite revenue decline.
Salt segment offset volume declines with higher prices, while Plant Nutrition volumes grew but margins fell.
Year-end liquidity was $189.9 million, with plans to refinance debt in 2025.
Financial highlights
Fiscal 2024 revenue was $1,117.4 million, down 7% year-over-year; Salt revenue down 10%, Plant Nutrition up 5%.
Q4 net loss was $48.3 million, including a $17.6 million write-down of Utah water rights.
Full-year operating loss was $116.8 million; adjusted operating loss was $12.8 million.
Adjusted EBITDA margin for fiscal 2024 was 18.5%.
Net cash from operating activities was $14.4 million, down from $106.0 million YoY.
Outlook and guidance
Fiscal 2025 Salt sales volumes expected to increase ~9% year-over-year; revenue guidance $940–$1,040 million, adjusted EBITDA $225–$250 million.
Plant Nutrition 2025 sales volumes projected at 285–305k tons, revenue $175–$195 million, adjusted EBITDA $14–$20 million.
Total company adjusted EBITDA guidance for 2025 is $169–$209 million after corporate expenses.
Capital expenditures for 2025 projected at $100–$110 million, including $10–$15 million for major projects.
No Fortress revenue included in 2025 outlook pending contract discussions.
Latest events from Compass Minerals International
- All voting items passed and no stockholder questions were raised during the meeting.CMP
AGM 20266 Mar 2026 - Q1 2026 net income hit $18.6M, EBITDA doubled, and guidance was raised on strong salt results.CMP
Q1 20266 Feb 2026 - Shareholders will vote on directors, executive pay, and auditor, with a focus on governance and ESG.CMP
Proxy Filing23 Jan 2026 - Key votes include director elections, executive pay, and auditor ratification for 2026.CMP
Proxy Filing23 Jan 2026 - Q1 FY2025 revenue down 10%, net loss narrowed, and Plant Nutrition volumes rose.CMP
Q1 202516 Dec 2025 - Net loss narrowed, debt fell, and 2026 guidance targets margin and EBITDA growth.CMP
Q4 20259 Dec 2025 - Proxy covers director elections, executive pay, incentive plan amendment, auditor ratification, and ESG goals.CMP
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, incentive plan, and auditor ratification.CMP
Proxy Filing1 Dec 2025 - Corrected auditor fees show KPMG received $3.8M in 2024, with prior years restated.CMP
Proxy Filing1 Dec 2025